Cerebrospinal fluid biomarker development in amyotrophic lateral sclerosis by Thompson, AG

Untangling neuroinflammation in amyotrophic lateral sclerosis by Thompson, AG, Turner, MR

Primary care blood tests show lipid profile changes in pre-symptomatic amyotrophic lateral sclerosis by Thompson, AG, Marsden, R, Talbot, K, Turner, MR

Apolipoproteins, lipids, lipid-lowering drugs and risk of amyotrophic lateral sclerosis and frontotemporal dementia: a meta-analysis and Mendelian randomisation study by Chalitsios, CV, Ley, H, Gao, J, Turner, MR, Thompson, AG

Data-independent acquisition proteomics of cerebrospinal fluid implicates endoplasmic reticulum and inflammatory mechanisms in amyotrophic lateral sclerosis by Dellar, ER, Vendrell, I, Talbot, K, Kessler, B, Fischer, R, Turner, MR, Thompson, AG

Network analysis of the CSF proteome characterizes convergent pathways of cellular dysfunction in ALS by Thompson, AG, Talbot, K, Gray, E, Charles, PD, Hu, MTM, Fischer, R, Kessler, BM, Turner, MR

Advancing mechanistic understanding and biomarker development in amyotrophic lateral sclerosis by Thompson, AG, Oeckl, P, Feneberg, E, Bowser, R, Otto, M, Fischer, R, Kessler, B, Turner, MR

Non-neuronal cells in amyotrophic lateral sclerosis — from pathogenesis to biomarkers by Vahsen, BF, Gray, E, Thompson, AG, Ansorge, O, Anthony, DC, Cowley, SA, Talbot, K, Turner, MR

CSF extracellular vesicle proteomics demonstrates altered protein homeostasis in amyotrophic lateral sclerosis by Thompson, AG, Gray, E, Mäger, I, Thézénas, M-L, Charles, PD, Talbot, K, Fischer, R, Kessler, BM, Wood, M, Turner, MR

Identification of a potential non-coding RNA biomarker signature for amyotrophic lateral sclerosis by Joilin, G, Gray, E, Thompson, AG, Bobeva, Y, Talbot, K, Weishaupt, J, Ludolph, A, Malaspina, A, Leigh, PN, Newbury, SF, Turner, MR, Hafezparast, M

Elevated cerebrospinal fluid ubiquitin carboxyl-terminal hydrolase isozyme L1 in asymptomatic C9orf72 hexanucleotide repeat expansion carriers by Dellar, ER, Vendrell, I, Amein, B, Lester, DG, Yoganathan, K, Dharmadasa, T, Sogorb‐Esteve, A, Fischer, R, Talbot, K, Rohrer, JD, Turner, MR, Thompson, AG, Edmond, EC

An ALS-linked mutation in TDP-43 disrupts normal protein interactions in the motor neuron response to oxidative stress by Feneberg, E, Gordon, D, Thompson, AG, Finelli, MJ, Dafinca, R, Candalija, A, Charles, PD, Mäger, I, Wood, MJ, Fischer, R, Kessler, BM, Gray, E, Turner, MR, Talbot, K

Multicentre appraisal of amyotrophic lateral sclerosis biofluid biomarkers shows primacy of blood neurofilament light chain by Thompson, AG, Gray, E, Verber, N, Bobeva, Y, Lombardi, V, Shepheard, SR, Yildiz, O, Feneberg, E, Farrimond, L, Dharmadasa, T, Gray, P, Edmond, EC, Scaber, J, Gagliardi, D, Kirby, J, Jenkins, TM, Fratta, P, McDermott, CJ, Manohar, SG, Talbot, K, Malaspina, A, Shaw, PJ, Turner, MR

Cerebrospinal fluid and blood biomarkers for Neurodegenerative Dementias: an update of the consensus of the Task Force on Biological Markers in Psychiatry of the World Federation o... by Lewczuk, P, Riederer, P, O'Bryant, SE, Verbeek, MM, Dubois, B, Visser, PJ, Jellinger, KA, Engelborghs, S, Ramirez, A, Parnetti, L, Jack, CR, Teunissen, CE, Hampel, H, Lleó, A, Jessen, F, Glodzik, L, de Leon, MJ, Fagan, AM, Molinuevo, JL, Jansen, WJ, Winblad, B, Shaw, LM, Andreasson, U, Otto, M, Mollenhauer, B, Wiltfang, J, Turner, MR, Zerr, I, Handels, R, Thompson, AG, Johansson, G, Ermann, N, Trojanowski, JQ, Karaca, I, Wagner, H, Oeckl, P, Doorn, L, Bjerke, M, Kapogiannis, D, Kuiperij, HB, Farotti, L, Li, Y, Gordon, BA, Epelbaum, S, Vos, SJB, Klijn, C, Van Nostrand, WE, Minguillon, C, Schmitz, M, Gallo, C, Mato, AM, Thibaut, F, Lista, S, Alcolea, D, Zetterberg, H, Blennow, K, Kornhuber, J